Dexmethylphenidate
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial.
Journal: Journal of child and adolescent psychopharmacology
Published: July 22, 2026
Dexmethylphenidate-associated hemorrhagic bullous IgA vasculitis.
Journal: JAAD case reports
Published: May 06, 2026
Advances in management of sarcoidosis-associated fatigue: A narrative review.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: January 04, 2026
Real-world evaluation of attention deficit hyperactivity disorder symptoms and side effects in patients prescribed serdexmethylphenidate/dexmethylphenidate or other stimulants.
Journal: Frontiers in pharmacology
Published: December 16, 2025
Consecutive double chiral-switches strategy. ADHD methylphenidate drugs: from two racemates via racemate to enantiomer.
Journal: Future medicinal chemistry
Published: October 09, 2025
Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management.
Journal: Current opinion in pulmonary medicine
Published: September 24, 2025
Methylphenidate-Type Psychostimulants for Cancer-Related Fatigue: Updated Meta-Analysis of Randomized Controlled Trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 25, 2025
Methylphenidate and Its Impact on Redox Balance and Behavior.
Journal: Journal of xenobiotics
Published: July 31, 2025
Methylphenidate in improving cancer-related fatigue: efficacy and safety - systematic review and meta-analysis of randomised controlled trials with trial sequential analysis.
Journal: BMJ supportive & palliative care
Published: July 10, 2025
Last Updated: 09/26/2026